Japan Times
Another iPS product approved for public insurance coverage in Japan
It is the second case of insurance coverage approval in the nation for an induced pluripotent stem cell-derived regenerative medicine product.
View original source — Japan Times ↗
Related stories
Portugal Resident
HealthJul 22, 2026 · 1 min
Ambulance delays at Algarve hospitals are “putting lives at risk” – firefighters and municipalities
Portugal Resident
Indian Express
HealthJul 22, 2026 · 1 min
Mini strokes rising in young adults: Warning signs you should never ignore
Indian Express
The Punch
HealthJul 22, 2026 · 1 min
Police arrest fake doctor over N500,000 job scam in Cross River
The Punch
Philippine Daily Inquirer
HealthJul 22, 2026 · 1 min
2 motorcyclists, 2 pedestrians dead in Quezon accidents
Philippine Daily Inquirer